A1 Refereed original research article in a scientific journal

Role of patient characteristics in adherence to first-line treatment guidelines in breast, lung and prostate cancer: insights from the Nordic healthcare system




AuthorsSandström Niclas, Leppälä Emilia, Jekunen Antti, Johansson Mikael, Andersén Heidi

PublisherBMJ Group

Publication year2024

JournalBMJ Open

Journal name in sourceBMJ open

Journal acronymBMJ Open

Article numbere084689

Volume14

Issue4

ISSN2044-6055

eISSN2044-6055

DOIhttps://doi.org/10.1136/bmjopen-2024-084689(external)

Web address https://bmjopen.bmj.com/content/14/4/e084689(external)

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/387714584(external)


Abstract

Objectives This study investigates the influence of socioeconomic status, health literacy, and numeracy on treatment decisions and the occurrence of adverse events in patients with breast, lung, and prostate cancer within a Nordic healthcare setting.

Design A follow-up to a cross-sectional, mixed-methods, single-centre study.

Setting A Nordic, tertiary cancer clinic.

Participants A total of 244 participants with breast, lung and prostate cancer were initially identified, of which 138 first-line treatment participants were eligible for this study. First-line treatment participants (n=138) surpassed the expected cases (n=108).

Interventions Not applicable as this was an observational study.

Primary and secondary outcome measures The study’s primary endpoint was the rate of guideline adherence. The secondary endpoint involved assessing treatment toxicity in the form of adverse events.

Results Guideline-adherent treatment was observed in 114 (82.6%) cases. First-line treatment selection appeared uninfluenced by participants’ education, occupation, income or self-reported health literacy. A minority (3.6%) experienced difficulties following treatment instructions, primarily with oral cancer medications.

Conclusions The findings indicated lesser cancer health disparities regarding guideline adherence and treatment toxicity within the Nordic healthcare framework. A causal connection may not be established; however, the findings contribute to discourse on equitable cancer health provision.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:29